Utility of hydroxyurea in mast cell activation syndrome

Mast cell activation syndrome (MCAS) is a relatively recently recognized cause of chronic multisystem polymorbidity of a generally inflammatory theme. Patients with MCAS often report migratory soft tissue and/or bone pain which frequently responds poorly to typical (narcotic and non-narcotic) analge...

Descripción completa

Detalles Bibliográficos
Autor principal: Afrin, Lawrence B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851743/
https://www.ncbi.nlm.nih.gov/pubmed/24192267
http://dx.doi.org/10.1186/2162-3619-2-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851743/
https://www.ncbi.nlm.nih.gov/pubmed/24192267
http://dx.doi.org/10.1186/2162-3619-2-28

Ejemplares similares